Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Bafna Pharmaceuticals Ltd.	LIVE QUOTES

NSE: BAFNAPHBE BSE: 532989ISIN: INE878I01022INDUSTRY: Pharmaceuticals

BSE

Rs 78.13

Open: 78.13

Today's Range 78.13

78.13

NSE
Rs 80.03
+1.79 (+ 2.24 %)

+3.72 (+ 4.76 %)

Prev Close: 74.41

52 Week Range 67.80

94.80

Registered Address

Registered Office : Bafna Towers, NewÿNo.ÿ68,ÿOldÿNo. 299,ÿÿ ÿ, Thambu Chetty Street,

Chennai (Madras), Tamil Nadu - 600001

Tel: 044-25267517, 25270992, 42677555

Fax: 044-25231264

Email : info@bafnapharma.com

Website : http://www.bafnapharma.com

Key Officials

Name	Designation
Mr. Melagiri Sridhar	Chief Financial Officer
Mr. Bafna Mahaveer Chand	Chief Executive Officer
Mr. A Mohanachandran	Co. Secretary & Compl. Officer

Listings

BSE , MCXSX , NSE ,

StandaloneConsolidated

Quarterly Trends - Standalone

Rs. in Crs.

Financial Year	Mar 25	Dec 24	Sep 24
Sales	39.06	33.19	40.32
Other Income	1.03	0.19	1.02
Total Expenses	35.95	30.13	36.53
Depreciation	0.22	1.66	1.58
Net Profit / Loss	1.31	0.95	2.62
Equity Capital	23.66	23.66	23.66

Half Yearly Balance Sheet - Standalone

Rs. in Crs.

YearEnding	Mar 25	Mar 24	Mar 23
Face Value	10	10	10
Equity Share Capital	23.66	23.66	23.66
Reserves and Surplus	61.15	57.18	49.80
Total Non-Current Liabilities	16.42	12.76	9.65
Total Current Liabilities	51.85	54.08	46.48
Total Capital And Liabilities	153.08	147.68	129.58
Total Non-Current Assets	66.90	53.21	42.27
Total Current Assets	86.18	94.47	87.31
Total Assets	153.08	147.68	129.58

Quarterly Trends - Consolidated

Rs. in Crs.

Financial Year	Mar 20	Dec 19	Sep 19
Sales	13.13	10.93	11.57
Other Income	-0.67	0.03	0.59
Total Expenses	8.89	10.68	11.93
Depreciation	0.52	1.00	0.72
Taxation	1.58	-0.04	0.04
Net Profit / Loss	0.60	-22.33	-0.59
Equity Capital	2.37	23.66	23.66

Half Yearly Balance Sheet - Consolidated

Rs. in Crs.

YearEnding	Mar 20	Mar 19	Mar 18
Face Value	10	10	10
Equity Share Capital	2.37	23.66	23.66
Reserves and Surplus	48.75	-4.60	14.27
Minority Interest	0.08	-0.21	0.00
Total Non-Current Liabilities	0.00	29.80	41.31
Total Current Liabilities	20.12	70.82	59.85
Total Capital And Liabilities	71.31	119.47	139.09
Total Non-Current Assets	35.22	71.00	90.35
Total Current Assets	36.10	48.47	48.74
Total Assets	71.31	119.47	139.09

Corporate News

Bafna Pharmaceutical - Trading Window-XBRL

Bafna Pharmaceutical - Trading Window

Bafna Pharmaceutical - Change in Directors/ Key Managerial P...

Bafna Pharmaceutical - Retirement

Bafna Pharmaceutical - General Updates

Registrar Details

Cameo Corporate Services Ltd.

"Subramanian Building", No.1, Vth Floor, Club House Road

Chennai (Madras),600002,Tamil Nadu

Tel : 044-28460390 (5 Line

Fax : 28460129

BSENSE

Market Performance

Exchange	BSE	NSE
Last Traded Price (Rs.)	78.13	80.03
Last Traded Date	27/06/2025	27/06/2025
Last Traded Time	-	-
Change (%)	5.00%	2.29%
Day's Open (Rs.)	78.13	77.00
Previous Close (Rs.)	74.41	78.24
Day's High (Rs.)	78.13	80.65
Day's Low (Rs.)	78.13	77.00
Total Traded Qty	5	8037
Value (Rs. In Lacs)	0.00	6.44
Bid Price (Rs.)	0.00	0.00
Bid Quantity
Offer Price (Rs.)	0.00	0.00
Offer Quantity
Exchange Code	532989	BAFNAPHBE
Exchange Group	T	T

Board Meetings

Date	Purpose
26/05/2025	Audited Results
06/02/2025	Quarterly Results
11/11/2024	Quarterly Results

Share Holding Pattern as on 31/03/2025

Major Holder	No. of Shares	Percentage (%)
Promoters	17,742,251	75.00
Institutional Investors	2,018,257	8.53
Other Investors	1,278,301	5.40
General Public	2,617,526	11.06

Market

Derivatives

Mutual Fund

IPO

Quick Links

Bafna Pharmaceuticals Ltd.

LIVE QUOTES